Decheng Capital Management III as of Dec. 31, 2022
Portfolio Holdings for Decheng Capital Management III
Decheng Capital Management III holds 26 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alabama Power Co. p | 18.5 | $49M | 6.7M | 7.35 | |
| Zentalis Pharmaceuticals (ZNTL) | 13.8 | $37M | 1.8M | 20.14 | |
| Prometheus Biosciences | 10.3 | $28M | 250k | 110.00 | |
| Cue Health (HLTHQ) | 7.0 | $19M | 9.0M | 2.07 | |
| Arcus Biosciences Incorporated (RCUS) | 6.7 | $18M | 870k | 20.68 | |
| Illumina (ILMN) | 6.1 | $16M | 81k | 202.20 | |
| Albireo Pharma | 5.0 | $14M | 623k | 21.61 | |
| 10x Genomics Cl A Com (TXG) | 4.9 | $13M | 360k | 36.44 | |
| Pacific Biosciences of California (PACB) | 4.5 | $12M | 1.5M | 8.18 | |
| BeyondSpring SHS | 3.5 | $9.3M | 5.0M | 1.88 | |
| Horizon Therapeutics | 3.4 | $9.0M | 79k | 113.80 | |
| Terns Pharmaceuticals (TERN) | 2.7 | $7.3M | 714k | 10.18 | |
| Aadi Bioscience (AADI) | 2.5 | $6.8M | 526k | 12.83 | |
| Mersana Therapeutics (MRSN) | 2.0 | $5.3M | 904k | 5.86 | |
| Adicet Bio (ACET) | 1.9 | $5.2M | 580k | 8.94 | |
| Equillium (EQ) | 1.8 | $4.9M | 4.4M | 1.10 | |
| Aura Biosciences (AURA) | 1.2 | $3.1M | 293k | 10.50 | |
| Seattle Genetics | 1.1 | $3.0M | 23k | 128.51 | |
| Argenx SE SHS (ARGX) | 0.8 | $2.1M | 5.5k | 378.83 | |
| AtriCure | 0.8 | $2.1M | 46k | 44.38 | |
| Apexigen | 0.5 | $1.3M | 1.9M | 0.68 | |
| GeneDx Holdings Corp. Com Cl A | 0.3 | $903k | 3.4M | 0.26 | |
| Scynexis Com New (SCYX) | 0.3 | $867k | 556k | 1.56 | |
| Nautilus Biotechnology (NAUT) | 0.2 | $540k | 300k | 1.80 | |
| Owlet Com Cl A | 0.2 | $502k | 898k | 0.56 | |
| Neubase Therapeutics Ord | 0.1 | $190k | 1.0M | 0.19 |
